'm interested in how many reviews have a negative conclustion (the treatment does not work, probably does not work, cannot be assumed to work). I have the suspicion that the conclusion is nearly always positive.
The editor Caroline mentioned is an exeption in this regard. Don't have the capacity to post the details now, but have a look at this and other reviews he was involved:
The pain group - PaPaS). He did a review in around 2010, and updated it a couple of times (after I had left) concluding in the end that despite many more studies being done with each subsequent review update, they were not good quality and so they still couldn't say whether the interventions were effective or not. His review is not a social or psychological intervention, but probably useless anyway!
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008208.pub5/full#CD008208-abs-0002.
Unfortunately, the most recent proocol he co-authored seems not to bother about the merely subjective outcomes thing and I haven't found out if that actually is what he criticized and led to his conclusions in the previous reviews. It sems to be important to read the protocols.
If anyone could have a closer look at this, that would be great.
Another issue is that you can't do higher quality trials if there are no adequate objective outcomes. No idea if he acknowledged this anywhere.
To objectively measure a more direct impact of arthtritis pain on movement, one perhaps had to measure how / whether patients' movement patterns of the affected joints/ limbs change.
If it comes to outcomes in ME trials it also seems important to me to acknowledge that it could be even easier to develop more objective measurements than for pain.
There are discussions on potential objective measures in ME and also those in MS related fatigue elsewhere on the forum.
Just to leave here some preliminary thoughts:
I think there are several lines of arguments to respond if some people argue that there are no robust measures for ME.
One line of arguing could be that less robust objective measures are better than merely subjective measures and there may exist analytical/ statistical means to make them more robust.
Another one could be to conclude that is not possible to do high quality non-blinded trials on ME until there are better objective measures, and it's possible and needed to develop these.